- 2019
- Press releases - 02.05.2019
Human “Jumping Genes” Caught in the Act!
Over the course of evolution, the genomes of most living organisms have grown more complex thanks to transposable elements, a.k.a. “jumping genes,” or DNA fragments that can move and copy themselves from one chromosome location to another. Researchers from Inserm, the CNRS, Université Côte d’Azur, and Université de Montpellier were able to capture these “jumping genes” just after they moved.
- Press releases - 30.04.2019
Fertility and endometriosis: a research update from Inserm
Today, around 1 in 8 couples seek help because they are struggling to conceive. Infertility has therefore become a public health problem, and the scientific community is rallying in response.
- Press releases - 17.04.2019
Artificial Intelligence Facilitates Chemical Toxicity Evaluation: the Case of Bisphenol S
A novel IT tool based on artificial intelligence methods has made it possible to identify the toxic effects of bisphenol S – a frequent substitute for bisphenol A in food containers.
- Press releases - 17.04.2019
The overall annual cost of infections due to bacterial resistance in French hospitals now estimated up to 290 million Euros
Une équipe de chercheurs est parvenue à estimer le nombre de nouveaux cas et le coût économique direct que représentent les infections à bactéries résistantes aux antibiotiques chez les malades hospitalisés, pendant les années 2015 et 2016.
- Press releases - 12.04.2019
Hypertension: A New Drug Coming Soon?
Firibastat is the first in a new class of antihypertensive drugs targeting the renin-angiotensin system in the brain.
- Press releases - 10.04.2019
ChroMS – the brain as never seen before
ChroMS is a new microscopy technique bringing together color, 3D and high-resolution imaging, and is nothing short of a revolution in vertebrate brain imaging.
- Press releases - 08.04.2019
Flu Shot: Cutaneous Administration Improves Efficacy
The team of Béhazine Combadière, Inserm Research Director at Unit 1135 “Center for Immunology and Infectious Diseases”, has been working for years on the impact of vaccine administration routes on the quality of immune responses.
- Press releases - 05.04.2019
Cesarean Delivery Linked to Increased Risk of Severe Maternal Complications
Cesarean delivery is thought to be linked to a greater risk of severe maternal complications – primarily hemorrhagic – than vaginal delivery, especially in women aged 35 and over.
- Press releases - 02.04.2019
Narcolepsy: A New Drug to Fight Sleepiness
How can the quality of life of patients with narcolepsy, the severest sleep disorder in humans, be improved? An international scientific team led by Yves Dauvilliers, a researcher at Inserm and Université de Montpellier, is working on Solriamfetol – a promising new drug that stimulates alertness and improves resistance to sleepiness.
- Press releases - 27.03.2019
Nanoblades: shuttles for genome surgery
Researchers are now able to edit the genome with precision using the “gene editing scissors” of CRISPR-Cas9, which is a highly promising tool for gene therapy. The technical challenge now is to get this tool into the genome of certain cells. With this in mind, a joint team from Inserm, the CNRS, the Université Claude Bernard Lyon 1, and the École Normale Supérieure de Lyon, working within the International Center for Infectiology Research (CIRI), have developed capsules that allow CRISPR-Cas9 to reach the target DNA: Nanoblades.